Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer
Author:
Affiliation:
1. Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Oncology
Reference50 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Epidemiology of gastric cancer: Global trends, risk factors and prevention;Rawla;Prz Gastroenterol,2019
3. Burden of gastric cancer;Thrift;Clin Gastroenterol Hepatol,2020
4. Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: Randomized, double-blind, phase III study (AVATAR study);Shen;Gastric Cancer,2015
5. Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): A randomised, open-label phase 3 trial;Lordick;Lancet Oncol,2013
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ADAM12 Silencing Mediated by FOXC2 Represses Meningioma Progression Through Inactivating the JAK1/STAT3/VEGFA Pathway;Biochemical Genetics;2024-07-27
2. Germline-specific RNA helicase DDX4 forms cytoplasmic granules in cancer cells and promotes tumor growth;Cell Reports;2024-07
3. Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment;Cancers;2024-01-31
4. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response;Cancer and Metastasis Reviews;2024-01-16
5. LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics;BMC Gastroenterology;2023-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3